妊娠期高血压疾病女性的血管生成标志物与母体超声心动图指标
这项前瞻性研究纳入95例妊娠期高血压疾病(HDP)孕妇和25例足月无并发症孕妇,在围产期进行经胸超声心动图和血sFlt-1、PlGF检测。HDP组sFlt-1与左心室质量指数(r=0.246;P=0.026)及E/e'比值(r=0.272;P=0.014)相关,PlGF与左心室质量指数相关(r=-0.238;P=0.031)。作者认为数据虽不能推断因果,但证实母体心血管系统与用于诊断和指示HDP严重程度的血管生成标志物之间存在密切关系。
要点
- HDP孕妇围产期sFlt-1与左心室质量指数及E/e'比值呈正相关。
- HDP孕妇PlGF与左心室质量指数呈负相关。
- 对照组sFlt-1/PlGF比值与侧壁e'及E/e'比值相关。
核心结论
- 现有数据不能推断因果关系,但证实母体心血管系统与用于诊断和指示HDP严重程度的血管生成标志物之间存在密切关系。
研究设计与样本
- 前瞻性研究,纳入95例妊娠期高血压疾病孕妇和25例足月无并发症妊娠孕妇,围产期(分娩前或分娩后一周内)行经胸超声心动图和血sFlt-1、PlGF检测,采用Spearman秩相关分析。
诊断标准与关键数值
- HDP组(n=83):sFlt-1与左心室质量指数相关(r=0.246;P=0.026),与E/e'比值相关(r=0.272;P=0.014)。
- HDP组(n=83):PlGF与左心室质量指数相关(r=-0.238;P=0.031)。
- HDP组:sFlt-1/PlGF比值与左心室质量指数相关(r=0.252;P=0.022),与E/e'比值相关(r=0.269;P=0.014)。
- 对照组(n=25):sFlt-1与相对室壁厚度相关(r=0.409;P=0.043),与侧壁e'相关(r=-0.562;P=0.004),与E/e'比值相关(r=0.417;P=0.042)。
- 对照组(n=25):PlGF与侧壁e'相关(r=0.466;P=0.022);sFlt-1/PlGF比值与侧壁e'相关(r=-0.568;P=0.004),与E/e'比值相关(r=0.428;P=0.037)。
局限性
- 作者指出现有数据不能推断因果关系。
- 12例HDP女性(12.6%)在分娩后采血和行经胸超声心动图,因血管生成标志物水平显著较低而被排除分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The maternal cardiovascular system of women with hypertensive disorders of pregnancy (HDP) can be impaired, with higher rates of left ventricular (LV) remodeling and diastolic dysfunction compared to those with normotensive pregnancy. The primary objective of this prospective study was to correlate cardiac indices obtained by transthoracic echocardiography (TTE) and circulating angiogenic markers, such as soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF).
METHODS: In this study, 95 women with a pregnancy complicated by HDP and a group of 25 with an uncomplicated pregnancy at term underwent TTE and blood tests to measure sFlt-1 and PlGF during the peripartum period (before delivery or within a week of giving birth). Spearman's rank correlation was used to derive correlation coefficients between biomarkers and cardiac indices in the HDP and control populations.
RESULTS: The HDP group included 61 (64.2%) pre-eclamptic patients and, among them, 42 (68.9%) delivered before 37 weeks' gestation. Twelve women with HDP (12.6%) underwent blood sampling and TTE after delivery, and, as they showed significantly lower levels of angiogenic markers, they were excluded from the analysis. There was a correlation between sFlt-1 and LV mass index (LVMI) (r = 0.246; P = 0.026) and early diastolic mitral inflow velocity (E) and early diastolic mitral annular velocity (e') ratio (r = 0.272; P = 0.014) in the HDP group (n = 83), while in the controls, sFlt-1 showed a correlation with relative wall thickness (r = 0.409; P = 0.043), lateral e' (r = -0.562; P = 0.004) and E/e' ratio (r = 0.417; P = 0.042). PlGF correlated with LVMI (r = -0.238; P = 0.031) in HDP patients and with lateral e' (r = 0.466; P = 0.022) in controls. sFlt-1/PlGF ratio correlated with lateral e' (r = -0.568; P = 0.004) and E/e' ratio (r = 0.428; P = 0.037) in controls and with LVMI (r = 0.252; P = 0.022) and E/e' ratio (r = 0.269; P = 0.014) in HDP.
CONCLUSIONS: Although the current data are not able to infer causality, they confirm the intimate relationship between the maternal cardiovascular system and angiogenic markers that are used both to diagnose and indicate the severity of HDP. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Giorgione V, Di Fabrizio C, Giallongo E, et al. Angiogenic markers and maternal echocardiographic indices in women with hypertensive disorders of pregnancy. Ultrasound Obstet Gynecol. 2024. PMID: 37675647. doi:10.1002/uog.27474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。